Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway

Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing

Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482 · see citing works

Molecular portraits of human breast tumours

Perou, C., Sørlie, T., Eisen, M., van de Rijn, M., Jeffrey, S., Rees, C. A., Pollack, J., Ross, D., Johnsen, H., Akslen, L., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,551 · see citing works

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

Sørlie, T., Perou, C., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M., van de Rijn, M., Jeffrey, S., et al. (2001) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.191367098 · Cited by 11,695 · see citing works

Statistical Methods for Research Workers

Fisher, R. A. (1945) · American Journal of Clinical Pathology · doi:10.1093/ajcp/15.11.552b · Cited by 10,883 · see citing works

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins

(2005) · The Lancet · doi:10.1016/s0140-6736(05)67394-1 · Cited by 6,848 · see citing works

Surfing the p53 network

Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607 · see citing works

Regulation of the mevalonate pathway

Goldstein, J. L., & Brown, M. S. (1990) · Nature · doi:10.1038/343425a0 · Cited by 5,394 · see citing works

SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver

Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15593 · Cited by 4,285 · see citing works

SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver

Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215593 · Cited by 4,092 · see citing works

Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures

Debnath, J., Muthuswamy, S. K., & Brugge, J. S. (2003) · Methods · doi:10.1016/s1046-2023(03)00032-x · Cited by 2,001 · see citing works

Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome

Olive, K. P., Tuveson, D. A., Ruhe, Z. C., Yin, B., Willis, N. A., Bronson, R. T., Crowley, D., & Jacks, T. (2004) · Cell · doi:10.1016/j.cell.2004.11.004 · Cited by 1,308 · see citing works

An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival

Miller, L. D., Smeds, J., George, J., Vega, V. B., Vergara, L. A., Ploner, A., Yudi Pawitan, Y., Hall, P. N., Klaar, S., Liu, E. T., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506230102 · Cited by 1,269 · see citing works

When mutants gain new powers: News from the mutant p53 field

Brosh, R., & Rotter, V. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2693 · Cited by 1,132 · see citing works

Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells.

PETERSEN, O. W., Rønnov‐Jessen, L., Howlett, A. R., & Bissell, M. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.19.9064 · Cited by 1,096 · see citing works

Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome

Lang, G. A., Iwakuma, T., Suh, Y.-A., Liu, G., Rao, V. A., Parant, J. M., Valentin-Vega, Y. A., Terzian, T., Caldwell, L. C., Strong, L. C., et al. (2004) · Cell · doi:10.1016/j.cell.2004.11.006 · Cited by 1,069 · see citing works

The morphologies of breast cancer cell lines in three-dimensional assays correlate with \ntheir profiles of gene expression

Kenny, P. A., Lee, G. Y., Myers, C. A., Neve, R. M., Semeiks, J. R., Spellman, P. T., Lorenz, K., Lee, E. H., Barcellos‐Hoff, M. H., PETERSEN, O. W., et al. (2008) · eScholarship (California Digital Library) · Cited by 1,039 · see citing works

TP53 mutations in human cancers: Functional selection and impact on cancer prognosis and outcomes

Petitjean, A., Achatz, M. I. W., Borresen-Dale, A. L., Hainaut, P., & Olivier, M. (2007) · Oncogene · doi:10.1038/sj.onc.1210302 · Cited by 884 · see citing works

Mutant p53 drives invasion by promoting integrin recycling

Muller, P. A. J., Caswell, P. T., Doyle, B., Iwanicki, M. P., Tan, E. H., Karim, S., Lukashchuk, N., Gillespie, D. A., Ludwig, R. L., Gosselin, P., et al. (2009) · Cell · doi:10.1016/j.cell.2009.11.026 · Cited by 796 · see citing works

A Mutant-p53/Smad Complex Opposes p63 to Empower TGFβ-Induced Metastasis

Adorno, M., Cordenonsi, M., Montagner, M., Dupont, S., Wong, C., Hann, B. C., Solari, A., Bobisse, S., Rondina, M. B., Guzzardo, V., et al. (2009) · Cell · doi:10.1016/j.cell.2009.01.039 · Cited by 783 · see citing works

Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein.Preprint

Lin, J., Chen, J., Elenbaas, B., & Levine, A. J. (1994) · Genes & Development · doi:10.1101/gad.8.10.1235 · Cited by 652 · see citing works

The organizing principle: microenvironmental influences in the normal and malignant breast

Bissell, M. J., Radisky, D. C., Rizki, A., Weaver, V. M., & PETERSEN, O. W. (2002) · Differentiation · doi:10.1046/j.1432-0436.2002.700907.x · Cited by 602 · see citing works

The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer.

Olivier, M., Langer√∏d, A., Carrieri, P., Bergh, J. C. S., Klaar, S., Eyfjord, J. E., Theillet, C. G., Rodríguez, C., Lidereau, R., Bièche, I., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1029 · Cited by 590 · see citing works

HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis

Wong, W. W.-L., Dimitroulakos, J., Minden, M., & Penn, L. Z. (2002) · Leukemia · doi:10.1038/sj.leu.2402476 · Cited by 579 · see citing works

Transcriptional regulation by p53: one protein, many possibilities

Laptenko, O., & Prives, C. L. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401916 · Cited by 500 · see citing works

Dysregulation of the mevalonate pathway promotes transformation

Clendening, J. W., Pandyra, A., Boutros, P. C., Ghamrasni, S. E., Khosravi, F., Trentin, G. A., Martirosyan, A., Hakem, A., Hakem, R., Jurišica, I., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910258107 · Cited by 419 · see citing works

Statin Prescriptions and Breast Cancer Recurrence Risk: A Danish Nationwide Prospective Cohort Study

Ahern, T. P., Pedersen, L., Tarp, M., Cronin-Fenton, D. P., Garne, J. P., Silliman, R. A., Sorensen, H. T., & Lash, T. L. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr291 · Cited by 387 · see citing works

Ras CAAX Peptidomimetic FTI-277 Selectively Blocks Oncogenic Ras Signaling by Inducing Cytoplasmic Accumulation of Inactive Ras-Raf Complexes

Lerner, E. C., Qian, Y., Blaskovich, M. A., Fossum, R. D., Vogt, A., Sun, J., Cox, A. D., Der, C. J., Hamilton, A. D., & Sebti, S. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.26802 · Cited by 361 · see citing works

Breast Cancer Growth Prevention by Statins

Campbell, M. J., Esserman, L. J., Zhou, Y., Shoemaker, M., Lobo, M., Borman, E., Baehner, F. L., Kumar, A. S., Adduci, K., Marx, C., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4061 · Cited by 349 · see citing works

Study of Failure Pattern Among High-Risk Breast Cancer Patients With or Without Postmastectomy Radiotherapy in Addition to Adjuvant Systemic Therapy: Long-Term Results From the Danish Breast Cancer Cooperative Group DBCG 82 b and c Randomized Studies

Nielsen, H. M., Overgaard, M., Grau, C., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.8738 · Cited by 348 · see citing works

Studies of the Isoprenoid-Mediated Inhibition of Mevalonate Synthesis Applied to Cancer Chemotherapy and Chemoprevention

Mo, H., & Elson, C. E. (2004) · Experimental Biology and Medicine · doi:10.1177/153537020422900701 · Cited by 340 · see citing works

3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors and the Risk of Cancer

Blais, L., Desgagné, A., & LeLorier, J. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.15.2363 · Cited by 326 · see citing works

miRNA-mRNA Integrated Analysis Reveals Roles for miRNAs in Primary Breast Tumors

Enerly, E., Steinfeld, I., Sahlberg, K. K., Leivonen, S., Aure, M. R. R., Russnes, H. G., Rønneberg, J. A., Johnsen, H., Navon, R., Rødland, E. A., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016915 · Cited by 306 · see citing works

Effects of statins and farnesyltransferase inhibitors on the development and progression of cancer

Graaf, M. R., Richel, D. J., Noorden, C. J. F. V., & Guchelaar, H. (2004) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2004.06.010 · Cited by 300 · see citing works

Microenvironmental Regulators of Tissue Structure and Function Also Regulate Tumor Induction and Progression: The Role of Extracellular Matrix and Its Degrading EnzymesPreprint

Bissell, M. J., Kenny, P. A., & Radisky, D. C. (2005) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2005.70.013 · Cited by 297 · see citing works

Sterol metabolism and SREBP activation

Sato, R. (2010) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2010.06.004 · Cited by 295 · see citing works

TP53mutation status and gene expression profiles are powerful prognostic markers of breast cancer

Langerød, A., Zhao, H., Borgan, Ø., Nesland, J. M., Bukholm, I. R., Ikdahl, T., Kåresen, R., Børresen‐Dale, A., & Jeffrey, S. S. (2007) · Breast Cancer Research · doi:10.1186/bcr1675 · Cited by 291 · see citing works

Detection of Isolated Tumor Cells in Bone Marrow Is an Independent Prognostic Factor in Breast Cancer

Wiedswang, G., Borgen, E., Kåresen, R., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.02.009 · Cited by 288 · see citing works

A Small Molecule That Blocks Fat Synthesis By Inhibiting the Activation of SREBP

Kamisuki, S., Mao, Q., Abu-Elheiga, L. A., Gu, Z., Kugimiya, A., Kwon, Y., Shinohara, T., Kawazoe, Y., Sato, S., Asakura, K., et al. (2009) · Chemistry & Biology · doi:10.1016/j.chembiol.2009.07.007 · Cited by 282 · see citing works

Modulation of the Vitamin D3 Response by Cancer-Associated Mutant p53

Stambolsky, P., Tabach, Y., Fontemaggi, G., Weisz, L., Maor-Aloni, R., Sigfried, Z., Shiff, I., Kogan, I., Shay, M., Kalo, E., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.11.025 · Cited by 245 · see citing works

Statins and risk of cancer: A systematic review and metaanalysis

Browning, D., & Martin, R. M. (2006) · International Journal of Cancer · doi:10.1002/ijc.22366 · Cited by 228 · see citing works

p53 Activation in Adipocytes of Obese Mice

Yahagi, N., Shimano, H., Matsuzaka, T., Najima, Y., Sekiya, M., Nakagawa, Y., Ide, T., Tomita, S., Okazaki, H., Tamura, Y., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302364200 · Cited by 220 · see citing works

Increased Sensitivity of Acute Myeloid Leukemias to Lovastatin-Induced Apoptosis: A Potential Therapeutic Approach

Dimitroulakos, J., Nohynek, D., Backway, K. L., Hedley, D. W., Yeger, H., Freedman, M. H., Minden, M. D., & Penn, L. Z. (1999) · Blood · doi:10.1182/blood.v93.4.1308 · Cited by 219 · see citing works

Fluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancer

Garwood, E. R., Kumar, A. S., Baehner, F. L., Moore, D. H., Au, A., Hylton, N. M., Flowers, C. I., Garber, J. E., Lesnikoski, B., Hwang, E. S., et al. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0507-x · Cited by 215 · see citing works

Genome-Wide Occupancy of SREBP1 and Its Partners NFY and SP1 Reveals Novel Functional Roles and Combinatorial Regulation of Distinct Classes of Genes

Reed, B. D., Charos, A. E., Szekely, A. M., Weissman, S. M., & Snyder, M. P. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000133 · Cited by 207 · see citing works

Global transcriptional program of p53 target genes during the process of apoptosis and cell cycle progression

Mirza, A., Wu, Q. J., Wang, L., McClanahan, T., Bishop, W. R., Gheyas, F., Ding, W., Hutchins, B., Hockenberry, T., Kirschmeier, P. T., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206477 · Cited by 183 · see citing works

Simvastatin induces derepression of PTEN expression via NFκB to inhibit breast cancer cell growth

Ghosh-Choudhury, N., Mandal, C. C., Ghosh-Choudhury, N., & Choudhury, G. G. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2009.12.010 · Cited by 178 · see citing works

Pro-proliferative FoxM1 is a target of p53-mediated repression

Barsotti, A. M., & Prives, C. L. (2009) · Oncogene · doi:10.1038/onc.2009.282 · Cited by 166 · see citing works

Lipid-Lowering Drug Use and Breast Cancer in Older Women: A Prospective Study

Cauley, J. A., Zmuda, J. M., Lui, L., Hillier, T. A., Ness, R. B., Stone, K. L., Cummings, S. R., & Bauer, D. C. (2003) · Journal of Women s Health · doi:10.1089/154099903322447710 · Cited by 153 · see citing works

Cholesterol inhibition, cancer, and chemotherapy

Buchwald, H. (1992) · The Lancet · doi:10.1016/0140-6736(92)90744-n · Cited by 146 · see citing works

Simvastatin Modulates Cytokine-Mediated Endothelial Cell Adhesion Molecule Induction: Involvement of an Inhibitory G Protein

Sadeghi, M. M., Collinge, M., Pardi, R., & Bender, J. R. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.5.2712 · Cited by 144 · see citing works

Molecular diversity in ductal carcinoma in situ (DCIS) and early invasive breast cancer

Muggerud, A. A., Hallett, M. T., Johnsen, H., Sahlberg, K. K., Zhou, W., Tahmasebpoor, S., Amini, R., Botling, J., Børresen‐Dale, A., Sørlie, T., et al. (2010) · Molecular Oncology · doi:10.1016/j.molonc.2010.06.007 · Cited by 132 · see citing works

Simvastatin induces apoptosis in human breast cancer cells: p53 and estrogen receptor independent pathway requiring signalling through JNK

Koyutürk, M., Ersöz, M., & Altıok, N. (2006) · Cancer Letters · doi:10.1016/j.canlet.2006.10.009 · Cited by 124 · see citing works

Two critical hydrophobic amino acids in the N-terminal domain of the p53 protein are required for the gain of function phenotypes of human p53 mutants.

Lin, J., Teresky, A. K., & Levine, A. J. (1995) · PubMed · Cited by 123 · see citing works

Lovastatin inhibits tumor growth and lung metastasis in mouse mammary carcinoma model: a p53-independent mitochondrial-mediated apoptotic mechanism

Shibata, M. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh201 · Cited by 118 · see citing works

High local recurrence risk is not associated with large survival reduction after postmastectomy radiotherapy in high-risk breast cancer: A subgroup analysis of DBCG 82 b&c

Kyndi, M., Overgaard, M., Nielsen, H. M., et al. (2008) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2008.04.014 · Cited by 115 · see citing works

Estrogen Receptor–Negative Breast Cancer Is Less Likely to Arise among Lipophilic Statin Users

Kumar, A. S., Benz, C. C., Shim, V., Minami, C. A., Moore, D. H., & Esserman, L. J. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0726 · Cited by 102 · see citing works

Reduction of lung metastasis, cell invasion, and adhesion in mouse melanoma by statin-induced blockade of the Rho/Rho-associated coiled-coil-containing protein kinase pathway

Kidera, Y., Tsubaki, M., Yamazoe, Y., Shoji, K., Nakamura, H., Ogaki, M., Satou, T., Itoh, T., Isozaki, M., Kaneko, J., et al. (2010) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-29-127 · Cited by 100 · see citing works

Conditional RNA interference in vivo to study mutant p53 oncogenic gain of function on tumor malignancy

Bossi, G., Marampon, F., Maor-Aloni, R., ZANI, B. M., Rotter, V., Oren, M., Strano, S., Blandino, G., & Sacchi, A. (2008) · Cell Cycle · doi:10.4161/cc.7.12.6161 · Cited by 92 · see citing works

Integrity of the N‐terminal transcription domain of p53 is required for mutant p53 interference with drug‐induced apoptosis

Matas, D., Sigal, A., Stambolsky, P., Milyavsky, M., Weisz, L., Schwartz, D., Goldfinger, N., & Rotter, V. (2001) · The EMBO Journal · doi:10.1093/emboj/20.15.4163 · Cited by 87 · see citing works

Potent, Highly Selective, and Non-Thiol Inhibitors of Protein Geranylgeranyltransferase-I

Vasudevan, A., Qian, Y., Vogt, A., Blaskovich, M. A., Ohkanda, J., Sebti, S. M., & Hamilton, A. D. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm9900873 · Cited by 84 · see citing works

Pooling breast cancer datasets has a synergetic effect on classification performance and improves signature stability

van Vliet, M. H., Reyal, F., Horlings, H. M., van de Vijver, M. J., Reinders, M. J. T., & Wessels, L. F. A. (2008) · BMC Genomics · doi:10.1186/1471-2164-9-375 · Cited by 84 · see citing works

Wild-type p53 in cancer cells: When a guardian turns into a blackguard

Kim, E. L., Giese, A., & Deppert, W. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.08.030 · Cited by 82 · see citing works

YM‐53601, a novel squalene synthase inhibitor, reduces plasma cholesterol and triglyceride levels in several animal species

Ugawa, T., Kakuta, H., Moritani, H., Matsuda, K., Ishihara, T., Yamaguchi, M., Naganuma, S., Iizumi, Y., & Shikama, H. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703545 · Cited by 82 · see citing works

Mutant p53 Disrupts MCF-10A Cell Polarity in Three-dimensional Culture via Epithelial-to-mesenchymal Transitions

Zhang, Y., Yan, W., & Chen, X. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.214585 · Cited by 80 · see citing works

Definition of a p53 transactivation function-deficient mutant and characterization of two independent p53 transactivation subdomains

Venot, C., Maratrat, M., Sierra, V., Conseiller, E., & Debüssche, L. (1999) · Oncogene · doi:10.1038/sj.onc.1202539 · Cited by 74 · see citing works

HMG-CoA reductase inhibitors: role in normal and malignant cells

Larsson, O. (1996) · Critical Reviews in Oncology/Hematology · doi:10.1016/1040-8428(96)00193-x · Cited by 72 · see citing works

A p53-independent role of Mdm2 in estrogen-mediated activation of breast cancer cell proliferation

Brekman, A., Singh, K. E., Polotskaia, A., Kundu, N., & Bargonetti, J. (2011) · Breast Cancer Research · doi:10.1186/bcr2804 · Cited by 71 · see citing works

A role for Chk1 in blocking transcriptional elongation of p21 RNA during the S-phase checkpointPreprint

Beckerman, R., Donner, A. J., Mattia, M., Peart, M. J., Manley, J. L., Espinosa, J. M., & Prives, C. L. (2009) · Genes & Development · doi:10.1101/gad.1795709 · Cited by 67 · see citing works

Multiple DNA Elements for Sterol Regulatory Element-Binding Protein and NF-Y Are Responsible for Sterol-Regulated Transcription of the Genes for Human 3-Hydroxy-3-Methylglutaryl Coenzyme A Synthase and Squalene Synthase

Inoue, J., Sato, R., & Maeda, M. (1998) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a022060 · Cited by 65 · see citing works

Expression levels of uridine 5'-diphospho-glucuronosyltransferase genes in breast tissue from healthy women are associated with mammographic density

Haakensen, V. D., Biong, M., Lingjærde, O. C., Holmen, M. M., Frantzen, J. O., Chen, Y., Navjord, D., Romundstad, L., Lüders, T., Bukholm, I. K., et al. (2010) · Breast Cancer Research · doi:10.1186/bcr2632 · Cited by 61 · see citing works

SREBP-2 and NF-Y are involved in the transcriptional regulation of squalene epoxidase

Nagai, M., Sakakibara, J., Nakamura, Y., Gejyo, F., & Ono, T. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00623-x · Cited by 57 · see citing works

A cAMP-Responsive Element Binding Site Is Essential for Sterol Regulation of the Human Lanosterol 14α-Demethylase Gene (CYP51)

Halder, S. K., Fink, M., Waterman, M. R., et al. (2002) · Molecular Endocrinology · doi:10.1210/me.2001-0262 · Cited by 55 · see citing works

Inhibition by 6-fluoromevalonate demonstrates that mevalonate or one of the mevalonate phosphates is necessary for lymphocyte proliferation.

Cuthbert, J. A., & Lipsky, P. E. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44789-2 · Cited by 53 · see citing works

Characterization of Functional Domains Necessary for Mutant p53 Gain of Function

Yan, W., & Chen, X. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.097253 · Cited by 40 · see citing works

Mutant p53 gain of function: The NF-Y connection

Peart, M. J., & Prives, C. L. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.08.014 · Cited by 34 · see citing works

Activation Domains from Both Monomers Contribute to Transcriptional Stimulation by Sterol Regulatory Element-binding Protein Dimers

Datta, S., & Osborne, T. F. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m411222200 · Cited by 32 · see citing works

Increased Sensitivity of Acute Myeloid Leukemias to Lovastatin-Induced Apoptosis: A Potential Therapeutic Approach

Dimitroulakos, J., Nohynek, D., Backway, K. L., et al. (1999) · Blood · doi:10.1182/blood.v93.4.1308.404k08_1308_1318 · Cited by 28 · see citing works

Sterol-regulatory-element-binding protein 2 and nuclear factor Y control human farnesyl diphosphate synthase expression and affect cell proliferation in hepatoblastoma cells

Ishimoto, K., Tachibana, K., Hanano, I., et al. (2010) · Biochemical Journal · doi:10.1042/bj20091511 · Cited by 28 · see citing works

In Silico Ascription of Gene Expression Differences to Tumor and Stromal Cells in a Model to Study Impact on Breast Cancer Outcome

Myhre, S., Mohammed, H., Tramm, T., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014002 · Cited by 27 · see citing works

Utilization of Genomic Signatures to Identify Phenotype-Specific Drugs

Mori, S., Chang, J. T., Andrechek, E. R., Potti, A., & Nevins, J. R. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006772 · Cited by 22 · see citing works

Inhibition of geranylgeranyltransferase inhibits bronchial smooth muscle hyperresponsiveness in mice

Chiba, Y., Sato, S., Hanazaki, M., et al. (2009) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00178.2009 · Cited by 20 · see citing works

Antineoplastic effects of simvastatin in experimental breast cancer.

Kubatka, P., Žihlavniková, K., Kajo, K., et al. (2011) · PubMed · Cited by 20 · see citing works

Characterization of the Mevalonate Kinase 5′-Untranslated Region Provides Evidence for Coordinate Regulation of Cholesterol Biosynthesis

Bishop, R. W., Chambliss, K. L., Hoffmann, G. F., et al. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7997 · Cited by 19 · see citing works

In vivo identification of promoter elements and transcription factors mediating activation of hepatic HMG-CoA reductase by T3

Boone, L. R., Niesen, M. I., Jaroszeski, M. J., et al. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.05.093 · Cited by 16 · see citing works

The morphologies of breast cancer cell lines in three‐dimensional assays correlate with their profiles of gene expression

Kenny, P. A., Lee, G. Y., Myers, C. A., Neve, R. M., Semeiks, J. R., Spellman, P. T., Lorenz, K., Lee, E. H., Barcellos-Hoff, M. H., Petersen, O. W., et al. (2007) · Molecular Oncology · doi:10.1016/j.molonc.2007.02.004 · Cited by 2 · see citing works

The emerging hallmarks of cancer metabolism

Pavlova, N. N., & Thompson, C. B. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.006 · Cited by 5,926 · see citing works

Putting p53 in context

Kastenhuber, E. R., & Lowe, S. W. (2017) · Cell · doi:10.1016/j.cell.2017.08.028 · Cited by 1,906 · see citing works

p53 mutations in cancer

Muller, P. A. J., & Vousden, K. H. (2013) · Nature Cell Biology · doi:10.1038/ncb2641 · Cited by 1,647 · see citing works

Statin use and reduced cancer-related mortality

Nielsen, S. F., Nordestgaard, B. G., & Bojesen, S. E. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1201735 · Cited by 1,030 · see citing works

Sterol regulatory element–binding proteins are essential for the metabolic programming of effector T cells and adaptive immunity

Kidani, Y., Elsaesser, H., Hock, M. B., Vergnes, L., Williams, K. J., Argus, J. P., Marbois, B. N., Komisopoulou, E., Wilson, E. B., Osborne, T. F., et al. (2013) · Nature Immunology · doi:10.1038/ni.2570 · Cited by 552 · see citing works

Therapeutic targeting of p53: all mutants are equal, but some mutants are more equal than others

Sabapathy, K., & Lane, D. P. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.151 · Cited by 517 · see citing works

Gain-of-function p53 mutants co-opt chromatin pathways to drive cancer growth

Zhu, J., Sammons, M. A., Donahue, G., Dou, Z., Vedadi, M., Getlik, M., Barsyte-Lovejoy, D., Al-awar, R., Katona, B. W., Shilatifard, A., et al. (2015) · Nature · doi:10.1038/nature15251 · Cited by 493 · see citing works

Mutant p53 Drives Pancreatic Cancer Metastasis through Cell-Autonomous PDGF Receptor β Signaling

Weissmueller, S., Manchado, E., Saborowski, M., Morris, J. P., Wagenblast, E., Davis, C. A., Moon, S.-H., Pfister, N. T., Tschaharganeh, D. F., Kitzing, T., et al. (2014) · Cell · doi:10.1016/j.cell.2014.01.066 · Cited by 466 · see citing works

The p53 Pathway in Glioblastoma

Zhang, Y., Dube, C., Gibert, M., Cruickshanks, N., Wang, B., Coughlan, M., Yang, Y., Setiady, I., Deveau, C., Saoud, K., et al. (2018) · Cancers · doi:10.3390/cancers10090297 · Cited by 440 · see citing works

Tumour-associated mutant p53 drives the Warburg effect

Zhang, C., Liu, J., Liang, Y., Wu, R., Zhao, Y., Hong, X., Lin, M., Yu, H., Liu, L., Levine, A. J., et al. (2013) · Nature Communications · doi:10.1038/ncomms3935 · Cited by 434 · see citing works

The molecular biology of pancreatic adenocarcinoma: Translational challenges and clinical perspectives

Wang, S., Zheng, Y., Yang, F., Zhu, L., Zhu, X.-Q., Wang, Z.-F., Wu, X.-L., Zhou, C.-H., Yan, J.-Y., Hu, B.-Y., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00659-4 · Cited by 369 · see citing works

A Designed Inhibitor of p53 Aggregation Rescues p53 Tumor Suppression in Ovarian Carcinomas

Soragni, A., Janzen, D. M., Johnson, L. M., Lindgren, A. G., Thai-Quynh Nguyen, A., Tiourin, E., Soriaga, A. B., Lu, J., Jiang, L., Faull, K. F., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2015.12.002 · Cited by 341 · see citing works

Mutant p53 in Cancer: Accumulation, Gain-of-Function, and Therapy

Yue, X., Zhao, Y., Xu, Y., Zheng, M., Feng, Z., & Hu, W. (2017) · Journal of Molecular Biology · doi:10.1016/j.jmb.2017.03.030 · Cited by 308 · see citing works

Acetyl-CoA metabolism in cancer

Guertin, D. A., & Wellen, K. E. (2023) · Nature Reviews Cancer · doi:10.1038/s41568-022-00543-5 · Cited by 303 · see citing works

Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer

Walerych, D., Lisek, K., Sommaggio, R., Piazza, S., Ciani, Y., Dalla, E., Rajkowska, K., Gaweda-Walerych, K., Ingallina, E., Tonelli, C., et al. (2016) · Nature Cell Biology · doi:10.1038/ncb3380 · Cited by 239 · see citing works

Statins as Anticancer Agents in the Era of Precision Medicine

Longo, J., van Leeuwen, J. E., Elbaz, M., Branchard, E., & Penn, L. Z. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-1967 · Cited by 196 · see citing works

Integrative proteogenomic characterization of hepatocellular carcinoma across etiologies and stages

Ng, C. K. Y., Dazert, E., Boldanova, T., Coto-Llerena, M., Nuciforo, S., Ercan, C., Suslov, A., Meier, M.-A., Bock, T., Schmidt, A., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29960-8 · Cited by 165 · see citing works

The role of tumor suppressor p53 in the antioxidant defense and metabolism

Budanov, A. V. (2014) · Subcellular Biochemistry · doi:10.1007/978-94-017-9211-0_18 · Cited by 157 · see citing works

Sustained SREBP-1-dependent lipogenesis as a key mediator of resistance to BRAF-targeted therapy

Talebi, A., Dehairs, J., Rambow, F., Rogiers, A., Nittner, D., Derua, R., Vanderhoydonc, F., Duarte, J. A. G., Bosisio, F., Van den Eynde, K., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04664-0 · Cited by 155 · see citing works

Osteosarcoma: Molecular Pathogenesis and iPSC Modeling

Lin, Y.-H., Jewell, B. E., Gingold, J., Lu, L., Zhao, R., Wang, L. L., & Lee, D.-F. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.06.004 · Cited by 150 · see citing works

p53 as a hub in cellular redox regulation and therapeutic target in cancer

Eriksson, S. E., Ceder, S., Bykov, V. J. N., & Wiman, K. G. (2019) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjz005 · Cited by 123 · see citing works

Regulation of nucleotide metabolism by mutant p53 contributes to its gain-of-function activities

Kollareddy, M., Dimitrova, E., Vallabhaneni, K. C., Chan, A., Le, T., Chauhan, K. M., Carrero, Z. I., Ramakrishnan, G., Watabe, K., Haupt, Y., et al. (2015) · Nature Communications · doi:10.1038/ncomms8389 · Cited by 127 · see citing works

Drugs Targeting p53 Mutations with FDA Approval and in Clinical Trials

Nishikawa, S., & Iwakuma, T. (2023) · Cancers · doi:10.3390/cancers15020429 · Cited by 115 · see citing works

Mutant p53 promotes tumor progression and metastasis by the endoplasmic reticulum UDPase ENTPD5

Vogiatzi, F., Brandt, D. T., Schneikert, J., Fuchs, J., Grikscheit, K., Wanzel, M., Pavlakis, E., Charles, J. P., Timofeev, O., Nist, A., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1612711114 · Cited by 99 · see citing works

Targeting Therapies for the p53 Protein in Cancer Treatments

Levine, A. J. (2019) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030518-055455 · Cited by 84 · see citing works

Regulation of Metabolic Activity by p53

Flöter, J., Kaymak, I., & Schulze, A. (2017) · Metabolites · doi:10.3390/metabo7020021 · Cited by 81 · see citing works

Lipophilic statins inhibit YAP nuclear localization, co-activator activity and colony formation in pancreatic cancer cells and prevent the initial stages of pancreatic ductal adenocarcinoma in KrasG12D mice

Hao, F., Xu, Q., Wang, J., Yu, S., Chang, H.-H., Sinnett-Smith, J., Eibl, G., & Rozengurt, E. (2019) · PLOS ONE · doi:10.1371/journal.pone.0216603 · Cited by 55 · see citing works

Effects of TP53 Mutations and miRs on Immune Responses in the Tumor Microenvironment Important in Pancreatic Cancer Progression

McCubrey, J. A., Yang, L. V., Abrams, S. L., Steelman, L. S., Follo, M. Y., Cocco, L., Ratti, S., Martelli, A. M., Augello, G., & Cervello, M. (2022) · Cells · doi:10.3390/cells11142155 · Cited by 49 · see citing works

Cancer therapeutic targeting using mutant–p53-specific siRNAs

Ubby, I., Krueger, C., Rosato, R., Qian, W., Chang, J., & Sabapathy, K. (2019) · Oncogene · doi:10.1038/s41388-018-0652-y · Cited by 50 · see citing works

Multimodal Metabolic Imaging Reveals Pigment Reduction and Lipid Accumulation in Metastatic Melanoma

Lee, H. J., Chen, Z., Collard, M., Chen, F., Chen, J. G., Wu, M., Alani, R. M., & Cheng, J.-X. (2021) · BME Frontiers · doi:10.34133/2021/9860123 · Cited by 38 · see citing works

ИСПОЛЬЗОВAНИЕ ПОТЕНЦИAЛA СОЦИAЛЬНЫХ ПAРТНЕРОВ В ПОДГОТОВКЕ БУДУЩИХ ПЕДAГОГОВ

Атабекова, Б. Б. (2024) · Habaršy. Pedagogika ġylymdary seriâsy · doi:10.51889/2959-5762.2023.80.4.019

The Novel Symbiotic Phenotype of Enhanced-Nodulating Mutant of Lotus japonicus: astray Mutant is an Early Nodulating Mutant with Wider Nodulation Zone

Nishimura, R., Ohmori, M., & Kawaguchi, M. (2002) · Plant and Cell Physiology · doi:10.1093/pcp/pcf098 · Cited by 60 · see citing works

Studies on a Temperature-sensitive Irreparable Mutant of Neurospora Crassa

Kuwana, H. (1960) · The Japanese Journal of Genetics · doi:10.1266/jjg.35.49 · Cited by 11 · see citing works

A new set of adsorption mutants of bacteriophage T4D: Identification of a new gene

Follansbee, S., Vanderslice, R. W., Chavez, L. G., et al. (1974) · Virology · doi:10.1016/0042-6822(74)90153-6 · Cited by 29 · see citing works

Phenotypic and genetic analysis of two reverse rolled leaf mutants

Shen, A. (2014) · Journal of Tianjin Normal University